“涌金系”出手，要约收购！

Core Viewpoint - Yongjin Investment plans to acquire 10% of ST Kelly's shares for approximately 371 million yuan, potentially becoming the controlling shareholder of the company [1][4]. Summary by Sections Acquisition Details - Yongjin Investment intends to offer 5.18 yuan per share to acquire 71.7 million shares of ST Kelly, which represents 10% of the company's total share capital [5][6]. - After the acquisition, Yongjin Investment will hold a total of 122 million shares, accounting for 16.99% of ST Kelly's total share capital [6]. Financial Performance of ST Kelly - ST Kelly has experienced poor financial performance, with a total decline of over 21% in stock price this year [10][12]. - The company reported a revenue of 985 million yuan for 2024, reflecting a year-on-year growth of 2.96%, but incurred a net loss of 106 million yuan [11]. Yongjin Investment's Financials - As of the end of 2024, Yongjin Investment's total assets amounted to 125.82 billion yuan, with total liabilities of 86.79 billion yuan, resulting in total equity of 39.03 billion yuan [7][8]. - The company reported revenues of 5.55 billion yuan in 2022, 4.99 billion yuan in 2023, and projected 4.78 billion yuan in 2024, with net profits of 1.31 billion yuan, 1.84 billion yuan, and 2.05 billion yuan respectively [9]. Historical Context - ST Kelly, established in 2005 and listed in 2012, specializes in the development and production of minimally invasive surgical systems for treating osteoporotic vertebral compression fractures [11]. - Yongjin Investment has been involved with ST Kelly since 2009 and became the largest shareholder in 2018, but the company has faced internal conflicts and a lack of a controlling shareholder in recent years [11].